Regis Technologies
Leo Formanski is an experienced chemist with a strong background in analytical method development and validation. Currently serving as an AMD Chemist at Regis Technologies since March 2017, Leo has focused on analytical methods. Prior to this role, Leo worked as an Analytical Chemist at Wockhardt USA from May 2010 to March 2017, specializing in HPLC within the QC Lab. Leo's career also includes a significant tenure as a Sr. Research Scientist at deCODE genetics from April 1998 to September 2009, where responsibilities included HPLC analysis of pharmaceutical samples. Leo holds both a Master of Science and a Bachelor of Science in Chemistry from DePaul University, earned in 1982 and 1979, respectively.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.